Helpful Drugs Never Cost-effective For any Very low Salary Shopper

There were many new biological drugs approved by the FDA to deal with psoriasis since 2003 as one example of an inflated drug price that many lower income people can’t obtain access to because Medicaid and Medicare won’t buy them because of the skyrocketing prices. The new blood thinner “Eliquis” is covered by Medicaid and Medicare at $200 a bottle. The COPD inhalers which are fairly new are also covered by the government without hesitation in the area of $150 a pop. Some states buy the very costly $400 and above hearing aids and some don’t. Why aren’t the brand new biological drugs that came out to deal with psoriasis since 2003 covered by the government?

I suppose this is one moment where I’m likely to answer the question I just asked of the articles readers. In the aforementioned linked article I posted to go with this article the writer states these biological drugs to deal with psoriasis will NOT be offered to individuals who are on Medicaid and Medicare because of price. All the drug companies who’ve created their particular biological psoriasis treatments have pushed people on Medicaid and Medicare from receiving treatment with your drugs through the high cost of the drugs. Medicare Part D prescription drug plan will pay the bulk cost of “biological’s” but the co pay is between $1200 and $5000 which still keeps folks from having the biological’s.

The spin is a number of these biological drug companies have programs to provide the drugs absolve to low income patients who’ve private insurance only. Drug companies have stated in several articles I’ve read that if the patients have Medicare or Medicaid they’ll NOT be qualified to receive the free programs.

Quote From GoodRX.com: The cheapest GoodRx price for the most typical version of Humira is around $5,130.76, 38% off the average retail price of $8,309.04.

These biological psoriasis treatments are not life saving so Medicare and Medicaid do not recognize the inflated cost by drug companies as an essential expense. The drug companies know this and want it this way. In 2003 when these biological psoriasis treatments were entering the drug marketplace they were affordable and insurance companies found the expense if your reasonable deductible was paid. After 2012 the insurance companies started to remove people with psoriasis since the payouts on the biological treatments were rising and getting extremely expensive.
The “Epipen Injector” used to deal with heroin overdoses was attacked viciously by the U.S. government when the master of the company jacked up the price so high only the truly wealthy could afford them. Medicaid and Medicare in a few states do cover generic Epipen’s but reject brand names. I’ve come to my conclusion about why this and other high drug costs are happening that keep some of those drugs from the reach of many individuals who are on Medicare and Medicaid.

Come ON! needless to say it’s collusion between the “Big Pharma” drug industry and members of congress. But when the collusion deals go south it’s the drug industry that’s forced to take the fall.

When these scams to achieve personal wealth come to light as in the opioid epidemic that’s ongoing now where billions of dollars are increasingly being paid out by the drug companies to the states our congressional representatives who profited from opioids though insider trading investments walk around without any potential for repercussion for their involvement in the scheme.

If you look at Canada which is a country where government has to pay for ALL healthcare costs you will see the cheapest prices on quality drugs anywhere because the government forces prices down to lessen government expenditures. All the drug companies that come up with high profit drug plans to fill their pockets are destroyed without question by the Canadian government. In the U.S. our congressional representatives steer thought from destroying excessive profit taking by the drug companies because they are committed to these drug companies for their particular personal profit. Congressional Representatives enter congress with meager wealth and leave with excessive riches.

I just bet ya if your person gained access to the investments of our congressional leaders they’d find many instances of drug company investments who’ve extremely high drug prices on popular needed drugs that really work to boost a persons health. Congress voted to provide drug companies a 20 year patent before generics could be produced with a 5 year extension if certain conditions are met knowing that high drug prices would develop giving congressional insiders great profit making investment opportunities.

I hear now and again on news shows the patent time has become 12 years but I haven’t seen this 12 year patent time frame in “Wikipedia” or anywhere else. All I see are 20 year patent time frames. I searched around and discovered following the drug is invented and a patent applied it may take around 8 years to get FDA approved which leaves 12 years for the drugs to remain on a patent.

Which of our congressional representatives would vote against this time honored tradition of screwing U.S. Citizens in the behind by increasing patent times so they could increase their particular personal cash value through outrageous drug prices?

So lets take the biological psoriasis drugs for instance since they have only been with us since 2003 or so. “Humira” was the very first biological patent approved by the FDA for the treatment of Rheumatoid Arthritis. Later on “Humira” was approved for the treatments of many other medical conditions including psoriasis.

If you have a 20 year patent on these drugs then “Humira” is likely to be priced out of reach of the general public until 2023 that has been a huge profit taking window for congressional representatives. “Skyrizi” which will be new this season in 2019 is priced around “$15,000” for a 12 months kit which will be 5 or 6 shots. “Humira” is injection and pill form. “Skyrizi” eliminates 90% of psoriasis with the very first two shots which are 4 weeks apart. “Skyrizi” will remain priced high until about 2039 when it has a 20 year patent.

When Humira comes from patent in 2023 it’ll send the manufacturing of it to the generic drug companies and drop the price to market value which can mean everyone on Medicaid and Medicare could have to be able to be treated with it. All biological drug manufacturers will be forced to drop their prices also to an acceptable level because ALL doctors will direct their patents to Humira leaving other drug companies with an item that can’t be sold because of price. In “India” an universal form of “Humira” has been manufactured and the monthly cost is $400 which will be only down a couple of hundred from the discounted prices in the U.S.. After “Humira” goes off patent in the U.S. even the generic “India” brand will fall in price even further.

I read it could cost a drug company over a million dollars to produce a drug but this is “Bull Hicky” ;.For just one think a drug company isn’t a drug company with no team of researchers. Actually a drug company is only researchers. A drug company after it starts building a profit from the drugs they manufactured in the very first place must budget for a permanent research team to produce future drug profits. The research team gets its paychecks from previous released drug sales always and forever and NO wockhardt lean recouping of costs for the development of a new drug is ever needed. A drug company is really a huge laboratory saturated in scientists that receives a commission regularly to produce new drugs and do constant experiments. No extra financial outputs are going on to operate a vehicle drug prices through the roof.

Popular new releases of drugs are only total profit magnets for drug companies and congressional representatives. It’s like the town or city you live in making you think that the fee to cope with a concern will exceed the taxes already collected to pay for the staff and resources to cope with the conditions that already are funded.

The “Stock Act” was enacted on April 4th, 2012 which required every person in congress to create their investment transactions on their websites within 45 days of making them for public viewing. Congressional representatives do not want their investments looked over nevertheless when public demand dictated that it become law to have their investments made public they had to provide into the public demand and folded to it. After having a year congress went against public demand on April 15th 2013 and voted to kill the parts of the law that would make their investments public. Congress couldn’t fulfill themselves at the cost of U.S. Citizens with riches galore through insider trading which they believe they have the right to do since there’s no legal entity that’ll punish them.

As Effective Drug Markets Grow Any Drugs Under Patents Sore In Price To The Point Only The Wealthy Can Afford Them. In 2012 The Drug Companies Decided Psoriasis Biological’s Were A Profit Maker In A Fast Growing Market. The Move Was Made To Raise The Prices So Extreme Profits Could Be Realized Through There Patent Monopoly Scheme Of Marketing To The Rich

Biological psoriasis drugs were priced reduced in 2012 and insurance companies covered them if a reasonable deductible was paid by someone who had a good job. After the market for biological,s started to grow the market became hijacked by the wealthy as an easy way to increase their personal values by increasing the prices and marketing these drugs to the wealthy and themselves who are the wealthy for massive profit taking. People who have been getting their psoriasis drugs covered through their insurance companies were being dropped off their insurance plans. Although insurance carriers covered biological’s before 2012 low income Medicaid and Medicare patients still did not have access to these drugs. Medicare Part D prescription plan pays the bulk of cost but the copay is $1200 to $5000 dollars meaning most Medicare patients do not have access to biological’s.

There’s no other way you will look at it. “Epipen’s” were getting the same treatment, they were introduced at a lowered price then hijacked for sale only to the wealthy which would produce high profits with decreased production costs. I keep running to the hearing aid conditions that were suppose to have been priced to the 1000s of dollars then being reduced to under $700 which will be still to expensive and an industry of massive profit taking. Hi-tech computer parts are cheaper than hearing aids?

With your drug companies as is by using any business who holds a monopoly on any needed or popular product through government mandate the higher prices only the wealthy can pay are dictated meaning less production is likely to be needed that means lower production costs and the same or older profit levels are kept. Production at market demand means higher manufacturing costs with lower profit margins.

Leave a Comment

Your email address will not be published.